Page last updated: 2024-09-05

atropine and seryl-leucyl-isoleucyl-glycyl--arginyl-leucinamide

atropine has been researched along with seryl-leucyl-isoleucyl-glycyl--arginyl-leucinamide in 1 studies

Compound Research Comparison

Studies
(atropine)
Trials
(atropine)
Recent Studies (post-2010)
(atropine)
Studies
(seryl-leucyl-isoleucyl-glycyl--arginyl-leucinamide)
Trials
(seryl-leucyl-isoleucyl-glycyl--arginyl-leucinamide)
Recent Studies (post-2010) (seryl-leucyl-isoleucyl-glycyl--arginyl-leucinamide)
26,7111,2591,697126035

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Hollenberg, MD; Irimajiri, K; Kawabata, A; Kawai, K; Kawao, N; Kuroda, R; Nishida, S; Nishikawa, H; Sakaguchi, Y; Tagome, A1

Other Studies

1 other study(ies) available for atropine and seryl-leucyl-isoleucyl-glycyl--arginyl-leucinamide

ArticleYear
Protease-activated receptor-2 (PAR-2) in the rat gastric mucosa: immunolocalization and facilitation of pepsin/pepsinogen secretion.
    British journal of pharmacology, 2002, Volume: 135, Issue:5

    Topics: Animals; Atropine; Capsaicin; Gastric Mucosa; Immunohistochemistry; In Vitro Techniques; Male; NG-Nitroarginine Methyl Ester; Oligopeptides; Omeprazole; Pepsin A; Pepsinogen A; Rats; Rats, Wistar; Receptor, PAR-2; Receptors, Thrombin; Stomach

2002